The dangers of chronic inflammation – and the worst things for it
Imagine a glowing couple in their 20s, working and partying hard, getting precious little sleep, says gastroenterologist Shilpa Ravella. Then fast-forward 30 years and the couple may have serious health issues such as Type 2 diabetes or heart disease.
'Late nights, drinking and stress, all these things trigger low-level inflammation which can damage our tissues and then one day it turns into heart disease or cancer,' adds Ravella. 'Yes, younger bodies tend to process things more favourably. But the processed food has got worse, and young onset colon cancer is skyrocketing.'
Being slim isn't a protection, adds Ravella. 'You can be at the gym lifting weights, have big muscles and a flat tummy, but still be highly inflamed. More importantly, you could have a higher risk of disease down the line, without having a clue.'
Hidden, chronic, low-grade, systemic inflammation is a 'hot topic' in health and wellness because it's increasingly recognised as a major driver of heart disease, cancer and Alzheimer's, as well as autoimmune conditions such as inflammatory bowel disease (IBD) and rheumatoid arthritis (where the immune system starts to attack the healthy cells of organs and tissues). And scientists now believe 'inflammaging' is one of several essential factors that drive ageing in humans.
'As we age, just naturally through a combination of genetics and the sum total of our environmental exposures, our immune systems develop a natural propensity for wanting to engage in chronic inflammation,' explains Dr Nathan Curran, a functional Medicine Practitioner at London's The Galen Clinic.
'If we're trying to prevent chronic disease, it needs to go beyond just screening for the disease,' he adds. 'We need to be screening for the actual triggers of the disease before they emerge.'
Inflammation isn't bad per se. It's the immune system's response to any traumatic event in the body tissues – for example, a scraped knee or finger cut. In case of 'acute' inflammation, our immune system releases inflammatory cells and cytokines (small proteins that stimulate more inflammatory cells) to neutralise the invading virus or start healing injured tissue. You will experience redness, warmth and swelling, but it will be over in a matter of days. 'Acute inflammation serves a very important role in keeping us alive,' says Dr Curran.
In our evolutionary history, in order to protect our bodies from pathogens and poisons, we developed a hyperactive immune system, explains Ravella, author of A Silent Fire: The Story of Inflammation, Diet and Disease.
The problem is inflammation is not always harmless.
'Chronic' inflammation happens when this response is switched on all the time, leaving your body in a constant state of alert. The body continues to send white blood cells on the attack in the absence of any threat. This disrupts normal bodily functions and can result in healthy tissues and organs being attacked. Plus your body never gets a chance to recuperate.
The whole topic of inflammation became a bit more 'personal' last October when I learnt I have 'a propensity for excessive inflammation on a genetic level' when I did a DNA test at Dr Curran's clinic.
The clues were there already: I had high cholesterol and was a point from being pre-diabetic. I sneezed incessantly (and very loudly) after too much fizz or sugar, both of which raise inflammation.
'You have an 'eager/active' variant of the gene,' Dr Curran tells me. 'This means a relatively mild trigger has the potential to trigger a disproportionately large/sustained release of TNF-alpha (a pro-inflammatory protein), unless we moderate the impact of this genetic variation through an anti-inflammatory lifestyle, omega-3s, Vitamin D and so on.'
I immediately Google TNF-alpha and find that, worryingly, this cytokine is implicated in acute and chronic inflammatory conditions including, sepsis, rheumatoid arthritis and dementia.
'Just because you have the genetic propensity doesn't mean it will be translated into excessive inflammation,' he adds, 'but you need to be mindful of your lifestyle and dietary exposures.'
But there's my family's history of heart disease to consider, too. 'When cholesterol accumulates in the arteries, it creates inflammation because it gets modified and oxidised,' explains British Heart Foundation Professor of Cardiovascular Medicine at the University of Cambridge, Ziad Mallat. 'And then the body recognises it as a stranger. This inflammation initially serves to clear the oxidised cholesterol from the arteries. But when the body is exposed continuously to this aggression, the clearance capacities become overwhelmed and the inflammation becomes chronic. This causes more build-up of fatty material in the arteries and later may create clots in the arteries, and cause heart attack and stroke. The same thing happens when you have high glucose in diabetes, or if you smoke; it causes injury to the arteries and that creates chronic inflammation.'
The shock motivated me to change my diet (I gave up free sugar, brought my cholesterol down naturally for this paper). Then in March I asked my GP for a CRP (C-reactive protein) blood test (CRP is produced by the liver and if there's a higher concentration of CRP than usual, it's a sign of inflammation) and, phew, it's normal at the moment. The sneezing has stopped.
'You were really lucky, because your sneezing was so obvious and not everybody has that,' says Thaddeus Stappenbeck, MD, PhD chair of Inflammation and Immunity at Cleveland Clinic. 'Most people have more vague symptoms, like they don't have the energy they used to, or they're not sleeping well.'
At Cleveland Clinic, Dr Thaddeus's research programme focuses on determining the root causes of inflammatory diseases with the goal of developing new therapies. 'With certain types of inflammatory conditions, they can programme parts of your immune system so they simply malfunction which further fuels inflammation later. A really good example is sepsis. Patients who have had bloodstream infections and spent time in intensive care, if they survive and are able to leave the hospital, what's well recognised is that parts of their immune system are no longer functional. So they're at risk for repeat infections with worse overall inflammation.'
The function of the immune system is to protect us from invaders—and to be able to tell apart the cells of our own body from other cells that don't belong to us. And scientists have estimated that about 70 per cent of the immune system lives in the gut microbiome. Chronic inflammation in the gut may be due to inflammatory bowel disease, such as Crohn's disease or ulcerative colitis. But a modern Western diet high in ultra-processed foods can literally cause our whole body to be on fire, too. The poorer the quality of a meal, the higher the inflammatory response. Our microbiome (and the trillions of bugs in our intestines crucial to human health) is worryingly damaged, in contrast to our ancestors who had better gut health.
This sort of inflammation contributes to most of our '21st-century' diseases, says Dr Stappenbeck. 'The link between what's going on in your gut microbiome, and diseases such as Alzheimer's, Parkinson's or sleep disorders or depression is really amazing. We're learning, for example, that Parkinson's disease probably starts in many of these patients in the colon and becomes more evident once brain lesions have developed. A lot of patients with Parkinson's have very severe constipation because the neurons in their colon are damaged and don't function properly. They could have been experiencing that for years without realising. So could we diagnose Parkinson's earlier before the cells of the brain are damaged?'
Many people don't know they have chronic inflammation until they're diagnosed with another condition, like rheumatoid arthritis or Type 2 diabetes.
Though patients may have experienced symptoms long before a formal diagnosis, says Dr Stappenbeck. 'We and others now recognise there are likely pre-existing conditions to Crohn's disease, for example. We see patients who start off by just feeling terrible, they're chronically tired, have brain fog, lethargy, some sort of GI disturbance. It's all connected.'
We still lack functional tests of our immune system to recognise people at risk. Though you can ask your GP to check inflammation levels with a CRP blood test to check inflammatory biomarkers (as part of your midlife check). C-reactive protein (CRP) in the blood may indicate infection or inflammation in the body which will require further testing. Though as Dr Curran reminds us, it could simply be caused by a common cold.
The good news is we can prevent, treat or even reverse chronic inflammation with medication and diet changes, says Ravella. 'You're able to see changes in the microbiome within a few days to weeks after changing your diet and that is going to jump-start positive change. From a disease-risk perspective, it may take longer.'
Modifications in diet, behaviour and lifestyle are the best place to start. 'People who are able to keep up those anti-inflammatory dietary and lifestyle factors throughout their lives, have a better chance of retaining the physical and mental functionality they had in their youth,' says Ravella. 'So that puts the way in which they age in a very different context. Obviously you will have the inflammation that's a natural part of ageing, but you're able to resolve inflammatory challenges far more seamlessly.'
Many inflammatory issues start in the gut, so we need a diverse diet, rich in foods that fight inflammation. 'What you include is actually much more important than what you exclude,' says Ravella. Aim for at least six portions of fruit/veg a day. Prioritise gut-friendly natural foods (leafy greens, like kale and spinach, plus cruciferous veg like broccoli, kale, cauliflower), grains, beans, spices and herbs which contain healthy fibre and chemicals.
Opt for healthy anti-inflammatory fats from sources like olive oil, nuts and seeds (chia seeds, flaxseed, walnuts, almonds). Studies have associated nuts with reduced markers of inflammation and a lower risk of cardiovascular disease and diabetes. Eat 50g of fibre a day (30g is not enough, argues Ravella). As well as oats and fibre-rich wholemeal bread, add in quinoa, bulgar, legumes each day. 'Fibre is one of our most anti-inflammatory foods that can actually manipulate the immune system, yet 90 per cent of UK adults are deficient in fibre,' says Ravella. Eat fatty fish like salmon, sardines, and mackerel. 'A diet rich in omega-3 from oily fish is very effective at quelling chronic inflammation,' says Dr Curran.
Diets high in processed meats, butter, sweets, sugary drinks and refined grains are linked to higher inflammation and an increased risk of coronary heart disease. Ultra-processed foods are highly inflammatory due to their high content of saturated fats, sugars, salt, and additives like emulsifiers and sweeteners, which can negatively impact the gut microbiome and trigger inflammation. 'They're like Frankenfoods,' says Ravella.
Sugar also feeds inflammatory microbes in the gut, damaging our gut microbiome and leading to more inflammation.
Among other things, booze profoundly disrupts your gut bacteria and gut and liver function. 'All the data suggests it's really a toxin, essentially equivalent to cigarettes in provoking chronic inflammation. Limiting exposure to alcohol as best you can is a good strategy,' says Dr Stappenbeck.
Aim for at least 150 minutes of moderate-intensity physical activity (like walking) per week. Partly because it can help to prevent obesity, which causes inflammation and partly because it comes with its own benefits. A 2017 study conducted by the University of California San Diego School of Medicine found that even one 20-minute session of moderate exercise can stimulate the immune system.
'Sleep is very important in draining toxic material from the brain through a specialised lymphatic system that cleans the brain, and it is very active at night,' says Prof Mallat, 'and all of this is very important in terms of shutting down inflammation.'
'Taking a walk in the woods can help us de-stress, but also exposes us to bacteria, viruses and fungi that can boost our own,' says Ravella. ' Too many people are on screens in concrete buildings and don't go out.'
Burnout exacerbates inflammation. 'If you are operating constantly in a state of constant threat perception, that will drive your immune system to a state of hyper-vigilance,' explains Dr Curran. 'Your thoughts are communicated to your immune system through stress hormones, so high levels of cortisol or adrenaline (all of the fight-or-flight signalling agents) shifts your immune system into a state of high alert, where the smallest trigger sets off a massive inflammatory cascade.'
Vitamin D is hugely important for regulating inflammation, says Dr Curran. It helps to support the body's immune response, improving your ability to fight off illness and disease.
Research based on workers during Ramadan in Indonesia suggests intermittent fasting can help limit inflammation. It can facilitate weight loss, prevent the progression of Type 2 diabetes and consequently improve cardiovascular risk, increase longevity, and reduce disease.
Certain cleaning supplies and body care products contain chemicals that may inflame us, so read labels carefully. 'We call it sterile inflammation,' says Dr Stappenbeck. 'Usually with inflammation, you have an infectious agent. But it's this sterile inflammation in the absence of any kind of infectious agent, that's worrying. We also need to further study the emerging role of microplastics and their interaction with the microbiome, especially in the gut, since this is something that's usually ingested.'
You can get a water filter and avoid bottled water, he adds, though the majority of microplastics come from our clothes when they are washed. So avoid polyester, nylon and acrylic. Choose natural fibres like cotton, wool, linen. Wash less frequently, use cold water, run full loads, and consider investing in a washing machine filter or a laundry bag designed to capture microplastics.
Air quality is also key. 'All the epidemiological studies suggest that in terms of lung disease, your post code, and how much pollution you breathe in really matters. A 2019 study by King's College London found London had the highest levels of airborne microplastics yet recorded, with a rate of microplastic deposition over 25 times higher than China, and seven times higher than Paris.
'If you live in an area with high amounts of air pollution, that's obviously going to affect your lung function, or if your water supply is contaminated with high amounts of microplastics.'
Air purifiers, especially those with HEPA filters, can effectively remove microplastics and other airborne pollutants. And if you live in a polluted are a like London avoid exercising outside at dawn or dusk when pollution peaks.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNET
10 hours ago
- CNET
The Aging Brain: 6 Things You Should Be Doing to Slow Cognitive Decline
When it comes to healthy aging, we tend to focus a lot on body health by exercising and eating well. One thing you might not be thinking about is brain health. But you should be. Your brain runs the rest of your body, and as we age, it changes, too. Cognition declines over time due to several factors, including age-related structure changes, brain injuries or excess stress hormones. According to the Centers for Disease Control and Prevention, one in nine American adults over 65 report cognitive decline. "The parts of our brain that help with learning information and remembering can become smaller, and the brain can weigh less as we age," said Colleen Marshall, chief clinical officer for Two Chairs. Aging doesn't happen at the same rate for everyone, but we all experience it in one way or another. Focusing on brain fitness now may help you slow the change and ensure your brain stays sharp through the years. How to start nourishing your brain for healthy aging 1) Solve puzzles We'll start with the easiest strategy to integrate into your daily life: puzzles. Solving puzzles can benefit the brain in several ways, from improving memory to boosting problem-solving skills. "They may slow the rate of cognitive decline and how quickly the brain decreases in size as we age," Marshall said. A study published in the journal Neurology reported that playing games like checkers or completing jigsaw puzzles can delay the onset of Alzheimer's by about five years. Different research supports the idea that solving crossword puzzles or journaling can lower the risk of dementia. Experts suggest that puzzles help curb cognitive decline because they expand the brain's cognitive reserve, or the ability to solve and cope with problems. Activities to try include putting together jigsaw puzzles or solving other types of puzzles, such as Sudoku, crosswords, memory games and math problems. 2) Learn a new skill Like stimulating the brain by playing games or solving puzzles, learning a new skill has short-term and long-term advantages. By learning a new skill, you're strategically activating several parts of your brain simultaneously. You're also promoting neuroplasticity by creating new pathways and strengthening those connections as you continue honing the skill. It could be learning a new language, painting or trying out a new sport. Just make sure it's challenging or complex, and continue to practice for the best brain results.3) Prioritize sleep Sleep is one of the most important things you can do for your body. While I'm not saying there's a right or wrong way to sleep, research suggests that how much sleep you get and the quality of your sleep influence your risk for dementia. According to a study published in the Journal of Neuroscience, a single night of sleep deprivation can age your brain. A lot goes on in the brain while we sleep, including clearing out toxins and creating new neural pathways. If you don't get enough sleep, your brain doesn't have time to carry out these functions and cognition suffers. Establishing a bedtime routine can have a big impact on your sleep quality. From reading a book to practicing yoga before bed, integrating relaxation into your night can help boost your sleep. 4) Focus on your nutrition What you eat also will influence the rate of cognitive decline you experience as you age. Studies have found that people who follow the Mediterranean and MIND (Mediterranean Dash Intervention for Neurodegenerative Delay) diets tend to have fewer cognitive impairments and dementias compared to those following other diets. More research is needed to conclude why this is true. However, it might have something to do with the way those diets prioritize foods that protect the brain with anti-inflammatory and antioxidant properties. Read more: Master the Mediterranean Diet With the Help of These Tips and Recipes No matter if you choose to follow a strict diet or just improve your current meal rotation, you'll want to focus on improving your blood sugar and dropping high levels of LDL cholesterol to reduce your risk of dementia. Foods to incorporate into your diet for better brain health: Leafy greens like spinach, kale and lettuce Salmon Dark berries Nuts Greek yogurt Dark chocolate Green tea Vegetables like broccoli and carrots 5) Exercise Studies have found that following an active lifestyle is associated with lower cognitive decline over time. Your heart rate increases when you exercise, which increases blood flow to the brain. This can help spark new development of nerve cells, a process called neurogenesis. Exercise also promotes increased connections between cells, making the brain more adaptive. Generally, any exercise that's good for the body will also help the mind. It doesn't have to be lifting weights; walking, swimming and dancing also achieve the same results. Read more: How Exercise Helps Boost Your Memory-Brain Health as You Age6) Make connections with others Marshall pointed out that prioritizing high-quality relationships with others can benefit the brain. According to a meta-analysis of longitudinal cohort studies, limited or poor relationships were associated with cognitive decline. Prioritizing social contact is an essential part of aging well. Whether spending time with your family or putting yourself out there at your local community center, staying connected is an integral part of aging gracefully. Too long; didn't read? Our brains change as we age; there is no way around it. However, integrating any of these easy habits into your routine can help nourish and safeguard your brain for the future. There are also a few things you should avoid to keep your brain in top shape. Heavy cigarette smoking has been associated with cognitive decline in middle age. Marshall added that heavy drinking, poor diet and unmanaged high blood pressure can also negatively impact the brain as we age. Don't worry; there's still time to turn it around. Even if you smoke now, quitting has the potential to return your risk of cognitive decline to a level that's comparable to those who never smoked.
Yahoo
13 hours ago
- Yahoo
There's a new blood test for Alzheimer's. Here's everything you need to know.
When you buy through links on our articles, Future and its syndication partners may earn a commission. The U.S. Food and Drug Administration (FDA) recently cleared a blood test that detects signs of Alzheimer's disease in the brain, according to multiple studies. This is the first-ever blood test available for this common form of dementia. Here's how the new blood test works and why it could be useful to patients. Alzheimer's disease is on the rise, in part because the age group most prone to dementia is growing larger. In the U.S., an estimated 7.2 million Americans ages 65 and older are living with Alzheimer's dementia in 2025. The percentage of affected people increases with age: About 5% of people ages 65 to 74 have Alzheimer's, compared with more than 33% of people ages 85 and older. At the point when a doctor has verified that a patient has cognitive decline, the blood test can be used in place of standard tests to see if they likely have Alzheimer's. Previously, gold-standard methods of diagnosing Alzheimer's have been more invasive and expensive, involving positron emission tomography (PET) scans, which use radioactive substances; and lumbar punctures, (also called spinal taps) during which a clinician uses a needle to sample spinal fluid from the low back. Clinicians also sometimes use MRIs or CT scans to rule out other causes of cognitive decline. The new test measures the ratio of two proteins in human blood, and this ratio correlates with the presence or absence of amyloid plaques, a primary sign of Alzheimer's found in the brain. For people experiencing memory lapses that might be due to Alzheimer's, the first step is to see their primary care physician (PCP), who should do a cognitive test. If there are signs of cognitive impairment, the patient would then be referred to a neurologist for an in-depth evaluation. Both dementia specialists and PCPs will be able to order this blood test to help with diagnosis, said Dr. Gregg Day, a neurologist with the Mayo Clinic in Jacksonville, Florida; Day led a study of the blood test published in June in the Journal of the Alzheimer's Association. A study published in 2024 in JAMA found that whether the test was ordered by a PCP or specialist, it was equally accurate at confirming suspected Alzheimer's diagnoses. PCPs could use the test results to decide whether to refer patients to a specialist, who could prescribe treatments such as lecanemab or donanemab, Day said. Or the PCP could personally prescribe a medicine like donepezil, which can help improve mental function in Alzheimer's. With FDA clearance, Medicare and private health insurance providers alike are expected to cover the new blood test, Day said. The test — called the "Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio" — is intended for people ages 55 and older who show signs and symptoms of cognitive decline that have been confirmed by a clinician. The test is designed for the early detection of amyloid plaques associated with Alzheimer's disease. (Amyloid plaques are unusual clumps found between brain cells and made up of a type of protein called beta-amyloid.) Related: Man nearly guaranteed to get early Alzheimer's is still disease-free in his 70s — how? Early detection is important, said Dr. Sayad Ausim Azizi, clinical chief of behavioral neurology and memory disorders at the Yale School of Medicine. That's because the Alzheimer's brain is like a rusty engine — the plaque is like rust settling onto the engine, interfering with the wheels' ability to turn, Azizi told Live Science. There are FDA-approved treatments that act like oil, helping the wheels to turn, but the medication does not remove the rust itself, he said. Available therapies can slow down the degradation of the brain by about 30% to 40%, studies show, so the patient can retain function for longer. "If you're driving now and living independently and you don't take the medicine, it's likely in five years you won't be able to do all these things," Azizi said, providing a hypothetical example. "If you take the medicine, the five years are extended to eight." If adopted as intended, the new blood test could help more people access these treatments sooner. The test is not recommended for the purposes of screening the general population. It is intended only for people who have been found by a doctor to exhibit signs of Alzheimer's disease, Day and Azizi emphasized. Some amount of amyloid is present in the brain during healthy aging, so its presence doesn't guarantee someone will later have Alzheimer's. If the test detects signs of amyloid plaques 20 years before any cognitive symptoms surface, Azizi explained, it would not make sense to treat the patient at that time. "The treatments are not 100% benign," he added. To receive lecanemab, for example, patients must be able to receive an infusion every two weeks at first and every four weeks later on; donanemab is given every four weeks. Both medications can come with infusion-related reactions, such as headache, nausea and vomiting. Rarely, the treatment donanemab can cause life-threatening allergic reactions, and both lecanemab and donanemab have been tied to rare cases of brain swelling or bleeding in the brain. These latter side effects are related to "amyloid-related imaging abnormalities," which are structural abnormalities that appear on brain scans. The new test can give false positives, meaning a person can potentially test positive when they don't actually have Alzheimer's. That's because the signs of amyloid that the tests look for can be tied to other conditions. For instance, amyloid buildup in the brain could be a sign the kidneys are not functioning optimally, Day said, so he recommends also doing a blood test for kidney function when ordering the Alzheimer's blood test. The Mayo Clinic study included about 510 people, 246 of whom showed cognitive decline; the blood test confirmed 95% of those with cognitive symptoms had Alzheimer's. About 5.3% of cases showed a false negative on the blood test, while 17.6% of cases gave a false positive, Day said. Most of the false-positive patients still had Alzheimer's-like changes in their brains, but their symptoms were ultimately attributed to other diseases, such as Lewy body dementia, Day said. The Mayo study found that the blood test helped doctors distinguish Alzheimer's from these other forms of dementia. As is true of many clinical trials, evaluations of the test have primarily included populations that are healthier than average, Day said. These individuals are not only healthier at baseline, but are more likely to have health insurance and be white and non-Hispanic. So when the blood test is used in a broader population, there may be people with sleep apnea or kidney disease who test positive despite not having Alzheimer's, Day said. Some people with these health problems may also experience memory issues or cognitive impairment that's not caused by Alzheimer's disease. If the blood test points to amyloid buildup, doctors could order additional tests and ask patients about their sleep to help rule out these other possibilities. RELATED STORIES —Could vaccines prevent and treat Alzheimer's disease? —Study unravels whole new layer of Alzheimer's disease —Alzheimer's comes in at least 5 distinct forms, study reveals The test will give researchers a more precise idea of how a patient's clinical symptoms relate to the findings on their blood test, Azizi said. "It's a great way of using a biomarker [measurable sign of disease] in the blood to make an earlier diagnosis to give a drug" to slow disease progression, he said. Azizi added that this blood test could help track whether a treatment for Alzheimer's disease is working, which would be useful both for patients receiving approved medicines and those in trials of new drugs. Looking forward, researchers will also be able to evaluate how well blood-based testing works in more diverse populations, Day noted. This article is for informational purposes only and is not meant to offer medical advice.


Newsweek
a day ago
- Newsweek
Scientists Map How Alzheimer's Begins in the Brain
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. In an unprecedented large-scale study, researchers have mapped out the first molecular events that cause harmful protein buildups in the brain of people with Alzheimer's disease. "By measuring the effects of over 140,000 different versions of proteins, we have created the first comprehensive map of how individual mutations alter the energy landscape of amyloid beta aggregation—a process central to the development of Alzheimer's disease," said paper author and computational biologist Anna Arutyunyan of the Wellcome Sanger Institute in a statement. "Our data-driven model offers the first high-resolution view of the reaction's transition state, opening the door to more targeted strategies for therapeutic intervention," Arutyunyan added. The Alzheimer's Association estimates that some 7.2 million Americans aged 65 and older are presently living with the disease. Its first outward symptom is typically memory problems, but it can lead to delusions, speech issues, disturbed sleep and mood swings. Artist's impression of amyloid-beta peptide buildups within the brain. Artist's impression of amyloid-beta peptide buildups within the brain. selvanegra/iStock / Getty Images Plus At the heart of more than 50 different neurodegenerative diseases is the molecule amyloid beta. This peptide (a chain of amino acids) has a tendency to clump together, forming structures known as amyloid fibrils. In turn, these fibrils gather together into so-called "plaques"—which play a central role in the progression of Alzheimer's disease. The transition from free-flowing amyloid beta to stable fibril structures requires a certain amount of energy—with the peptides having to pass through a "transition state." This state is extremely unlikely to form, accounting for why fibrils and plaques never form in most people. It is also extremely short-lived, which helps account for how difficult it is to study how amyloid beta starts aggregating. Nevertheless, understanding these molecular structures and reactions will be vital for the future development of therapies against Alzheimer's and similar conditions. In the new study, Arutyunyan and colleagues probed the amyloid beta transition by exploring how changing the genetics of the peptide affects its aggregation rate. The team focused on Aβ42, a form of the amyloid beta with 42 amino acids that is commonly found in people with Alzheimer's disease. The researchers used three techniques in their work. First, "massively parallel sequencing" allowed the team to see how changing the amino acids in Aβ42 affects the amount of energy needed to form a fibril. Next, they used genetically engineered yeast cells to measure the rate of the aggregation reaction. Finally, the team used machine learning tools to analyze the results and map out the effect of all the possible mutations of the peptide on fibril formation. In total, the team were able to assess more than 140,000 versions of Aβ42 in one pop—a breakthrough in scale that boosts the accuracy of the resulting models. Read more Map shows states where risk of dementia is highest—are you living in one? Map shows states where risk of dementia is highest—are you living in one? The analysis revealed that only a very few specific interactions between parts of the amyloid beta peptide strongly influenced the rate of fibril formation. Furthermore, the team found that the aggregation reaction begins at one of the tightly packed, water-repellent ends of the peptide, which is known as the C-terminal region. Accordingly, the researchers hope that targeting interactions in this region might allow new means to protect against and treat Alzheimer's disease. "The approach we used in this study opens the door to revealing the structures of other protein transition states, including those implicated in other neurodegenerative diseases," said genomicist professor Ben Lehner, also of the Wellcome Sanger Institute, in a statement. "The scale at which we analyzed the amyloid peptides was unprecedented … we have shown it's a powerful new method to take forward. "We hope this takes us one step closer to developing treatments against Alzheimer's disease and other neurodegenerative conditions," Lehner added. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about Alzheimer's disease? Let us know via health@ Reference Arutyunyan, A., Seuma, M., Faure, A. J., Bolognesi, B., & Lehner, B. (2025). Massively parallel genetic perturbation suggests the energetic structure of an amyloid-β transition state. Science Advances, 11 (24).